Aetna prior authorization and CPT code lookup, page 21
CPT code lookup
Each row is one code from the participating-provider precertification list. This is not a coding dictionary, and it is not a coverage decision. The description is the service name on that list.
Participating-provider outpatient list
Inpatient, emergency, and observation settings are outside this outpatient list. This page does not publish a determination for those settings.
Prior authorization codes
| Code | Description | Source |
|---|---|---|
| Q5161 | Osteoporosis drugs: Bosaya (denosumab-kyqq) — precertification required effective April 1, 2026 | Participating provider precertification list for Aetna, Pg 29 Original policy |
| Q5158 | Osteoporosis drugs: Conexxence (denosumab-bnht) | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3490 | Osteoporosis drugs: denosumab-bnht | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3590 | Osteoporosis drugs: denosumab-bnht | Participating provider precertification list for Aetna, Pg 29 Original policy |
| C9399 | Osteoporosis drugs: denosumab-bnht | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3490 | Osteoporosis drugs: denosumab-dssb | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3590 | Osteoporosis drugs: denosumab-dssb | Participating provider precertification list for Aetna, Pg 29 Original policy |
| C9399 | Osteoporosis drugs: denosumab-dssb | Participating provider precertification list for Aetna, Pg 29 Original policy |
| Q5167 | Osteoporosis drugs: Enoby (denosumab-qbde) — precertification required Effective April 1, 2026 | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3111 | Osteoporosis drugs: Evenity (romosozumab-aqqg) — precertification required for the drug and site of | Participating provider precertification list for Aetna, Pg 29 Original policy |
| J3110 | Forteo (teriparatide) — precertification required for Medicare Advantage members only | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5136 | Jubbonti (denosumab-bbdz) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5166 | Jubereq (denosumab-desu) — precertification required effective April 1, 2026 — precertification required for site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J0630 | Miacalcin (calcitonin) — precertification required for Medicare Advantage members only | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5157 | Osenvelt (denosumab-bmwo) — precertification required for the drug and site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5159 | Ospomyv (denosumab-dssb) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5166 | Osvyrti (denosumab-desu) — precertification required effective April 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5165 | Oziltus (denosumab-mobz) — precertification required effective July 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5173 | Ponlimsi (denosumab-adet) — precertification required effective May 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J0897 | Prolia (denosumab) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5157 | Stoboclo (denosumab-bmwo) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J3110 | Teriparatide — precertification required for | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5136 | Wyost (denosumab-bbdz) — precertification required for the drug and site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5159 | Xbryk (denosumab-dssb) — precertification required for the drug and site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J0897 | Xgeva (denosumab) — precertification required for the drug and site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5167 | Xtrenbo (denosumab-qbde) — precertification required effective April 1, 2026 — precertification required for site of | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J3490 | Otarmeni (lunsotogene parvec-cwah) — precertification required effective July 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J3590 | Otarmeni (lunsotogene parvec-cwah) — precertification required effective July 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| C9399 | Otarmeni (lunsotogene parvec-cwah) — precertification required effective July 1, 2026 | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J0224 | Oxlumo (lumasiran) — precertification required for the drug and site of care | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9264 | Paclitaxel protein-bound particles (American Regent) — precertification required for Medicare Advantage members only | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9177 | Padcev (enfortumab vedotin) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5152 | drugs: (precertification required for the drug and site of care): Bkemv (eculizumab-aaeb) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| Q5151 | drugs: (precertification required for the drug and site of care): Epysqli (eculizumab-aagh) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J1299 | drugs: (precertification required for the drug and site of care): Soliris (eculizumab) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J1303 | drugs: (precertification required for the drug and site of care): Ultomiris (Ravulizumab-cwvz) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J0606 | Parsabiv (etelcalcetide) — precertification required for Commercial members only | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J3490 | (garetosmab-grts,) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J3590 | (garetosmab-grts,) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| C9399 | (garetosmab-grts,) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9023 | PD1/PDL1 drugs (precertification required for the drug and site of care): Bavencio (avelumab) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9173 | PD1/PDL1 drugs (precertification required for the drug and site of care): Imfinzi (durvalumab) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9272 | PD1/PDL1 drugs (precertification required for the drug and site of care): Jemperli (dostarlimab-gxly) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9271 | PD1/PDL1 drugs (precertification required for the drug and site of care): Keytruda (pembrolizumab) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9277 | PD1/PDL1 drugs (precertification required for the drug and site of care): berahyaluronidase alfa-pmph) | Participating provider precertification list for Aetna, Pg 30 Original policy |
| J9119 | Libtayo (cemiplimab-rwlc) | Participating provider precertification list for Aetna, Pg 31 Original policy |
| J3263 | Loqtorzi (toripalimab-tpzi) | Participating provider precertification list for Aetna, Pg 31 Original policy |
| J9299 | Opdivo (nivolumab) | Participating provider precertification list for Aetna, Pg 31 Original policy |
| J9289 | nvhy) | Participating provider precertification list for Aetna, Pg 31 Original policy |
| J9298 | Opdualag (nivolumab and relatlimab-rmbw) | Participating provider precertification list for Aetna, Pg 31 Original policy |
Aetna precertification list
The participating-provider examples point at the official list. Open the list itself for the current file, including its effective date.
Plan and setting exceptions
Student Health and Allina Health / Aetna are separate from the participating-provider rows above.
Prior authorization forms
| Product or plan | Benefit | Route |
|---|---|---|
| Use the plan named on the official form page | Medical and pharmacy forms are listed by Aetna | Aetna health care professional forms |
This page does not reproduce a form and does not list a fax number that was not read from the form page.